Ausgabe 5/2018
Inhalt (10 Artikel)
Key Issues and Potential Solutions for Understanding Healthcare Preference Heterogeneity Free from Patient-Level Scale Confounds
Catharina G. M. Groothuis-Oudshoorn, Terry N. Flynn, Hong Il Yoo, Jay Magidson, Mark Oppe
Symposium Title: Preference Evidence for Regulatory Decisions
Juan Marcos Gonzalez, F. Reed Johnson, Bennett Levitan, Rebecca Noel, Holly Peay
Accounting for Scale Heterogeneity in Healthcare-Related Discrete Choice Experiments when Comparing Stated Preferences: A Systematic Review
Stuart J. Wright, Caroline M. Vass, Gene Sim, Michael Burton, Denzil G. Fiebig, Katherine Payne
Themes that Determine Quality of Life in Patients with Peripheral Arterial Disease: A Systematic Review
Ahmed Aber, Elizabeth Lumley, Patrick Phillips, Helen Buckley Woods, Georgina Jones, Jonathan Michaels
Patient Preferences for Managing Insomnia: A Discrete Choice Experiment
Janet M. Y. Cheung, Delwyn J. Bartlett, Carol L. Armour, Bandana Saini, Tracey-Lea Laba
The Parker Model: Applying a Qualitative Three-Step Approach to Optimally Utilize Input from Stakeholders When Introducing New Device Technologies in the Management of Chronic Rheumatic Diseases
Tanja S. Jørgensen, Marie Skougaard, Peter C. Taylor, Hans C. Asmussen, Anne Lee, Louise Klokker, Louise Svejstrup, Irina Mountian, Henrik Gudbergsen, Lars Erik Kristensen
Patient Perspective on Acute Intermittent Porphyria with Frequent Attacks: A Disease with Intermittent and Chronic Manifestations
Amy Simon, Farrah Pompilus, William Querbes, Alex Wei, Sara Strzok, Craig Penz, Desiree Lyon Howe, Jessica R. Hungate, Jae B. Kim, Sonalee Agarwal, Patrick Marquis
Adaptation, Acceptance and Adaptive Preferences in Health and Capability Well-Being Measurement Amongst Those Approaching End of Life
Joanna Coast, Cara Bailey, Rosanna Orlando, Kathy Armour, Rachel Perry, Louise Jones, Philip Kinghorn
Understanding How Chorea Affects Health-Related Quality of Life in Huntington Disease: An Online Survey of Patients and Caregivers in the United States
Eileen Mack Thorley, Ravi G. Iyer, Paul Wicks, Chris Curran, Sanjay K. Gandhi, Victor Abler, Karen E. Anderson, Noelle E. Carlozzi
Patient-Reported Symptoms Over 48 Weeks Among Participants in Randomized, Double-Blind, Phase III Non-inferiority Trials of Adults with HIV on Co-formulated Bictegravir, Emtricitabine, and Tenofovir Alafenamide versus Co-formulated Abacavir, Dolutegravir, and Lamivudine
David Wohl, Amanda Clarke, Franco Maggiolo, Will Garner, Marianne Laouri, Hal Martin, Erin Quirk